Degang Yin1, Jingang Lu2, Jiansheng Wang3, Biao Yan3, Zhongshu Zheng4. 1. Department of Thoracic Surgery, Xixi Hospital, Hengbu Street 2, Xihu District, Hangzhou, 310023, China. dgy_yin@163.com. 2. Department of Anesthesiology, Xixi Hospital, Hangzhou, 310023, China. 3. Second Department of Surgery, Xixi Hospital, Hangzhou, 310023, China. 4. Department of Thoracic Surgery, Xixi Hospital, Hengbu Street 2, Xihu District, Hangzhou, 310023, China.
Abstract
BACKGROUND: The aim of the present study was to explore the therapeutic effect and prognosis in patients with rib fractures and atelectasis after thoracic trauma in order to provide a basis for clinical decision-making in primary hospitals. METHODS: A retrospective study was conducted on 86 patients admitted to our hospital between January 2016 and May 2020 with rib fractures and atelectasis after thoracic trauma. On the basis of the chest computed tomography scans taken at the time of discharge, the patients were divided into two groups: the reexpansion group and the non-reexpansion group. The two groups were compared with respect to the changes observed in the patients' levels of blood oxygen saturation (SpO2) and pulmonary function, the presence of secondary pulmonary or thoracic infection, the time of chest tube drainage, the length of hospitalization, the cost of hospitalization, and the patients' level of satisfaction with their quality of life 3 months after discharge. RESULTS: In the reexpansion group, there were significant differences in the levels of SpO2 and pulmonary function measured before and after pulmonary reexpansion (P < 0.05). Compared with the non-reexpansion group, the patients in the reexpansion group had a lower incidence of secondary pulmonary and thoracic infection and a higher level of satisfaction with their quality of life after discharge; these differences were statistically significant (P < 0.05). There was no statistical significance between the two groups with respect to the time of chest tube drainage or the length of hospitalization (P > 0.05). However, the cost of hospitalization was significantly higher in the reexpansion group than in the non-reexpansion group (P < 0.05). CONCLUSIONS: The patients in the pulmonary reexpansion group had a lower incidence of complications and a better prognosis than the patients in the non-reexpansion group.
BACKGROUND: The aim of the present study was to explore the therapeutic effect and prognosis in patients with rib fractures and atelectasis after thoracic trauma in order to provide a basis for clinical decision-making in primary hospitals. METHODS: A retrospective study was conducted on 86 patients admitted to our hospital between January 2016 and May 2020 with rib fractures and atelectasis after thoracic trauma. On the basis of the chest computed tomography scans taken at the time of discharge, the patients were divided into two groups: the reexpansion group and the non-reexpansion group. The two groups were compared with respect to the changes observed in the patients' levels of blood oxygen saturation (SpO2) and pulmonary function, the presence of secondary pulmonary or thoracic infection, the time of chest tube drainage, the length of hospitalization, the cost of hospitalization, and the patients' level of satisfaction with their quality of life 3 months after discharge. RESULTS: In the reexpansion group, there were significant differences in the levels of SpO2 and pulmonary function measured before and after pulmonary reexpansion (P < 0.05). Compared with the non-reexpansion group, the patients in the reexpansion group had a lower incidence of secondary pulmonary and thoracic infection and a higher level of satisfaction with their quality of life after discharge; these differences were statistically significant (P < 0.05). There was no statistical significance between the two groups with respect to the time of chest tube drainage or the length of hospitalization (P > 0.05). However, the cost of hospitalization was significantly higher in the reexpansion group than in the non-reexpansion group (P < 0.05). CONCLUSIONS: The patients in the pulmonary reexpansion group had a lower incidence of complications and a better prognosis than the patients in the non-reexpansion group.
Authors: Albert Faro; Robert E Wood; Michael S Schechter; Albin B Leong; Eric Wittkugel; Kathy Abode; James F Chmiel; Cori Daines; Stephanie Davis; Ernst Eber; Charles Huddleston; Todd Kilbaugh; Geoffrey Kurland; Fabio Midulla; David Molter; Gregory S Montgomery; George Retsch-Bogart; Michael J Rutter; Gary Visner; Stephen A Walczak; Thomas W Ferkol; Peter H Michelson Journal: Am J Respir Crit Care Med Date: 2015-05-01 Impact factor: 21.405